This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Richard Buick, PhD
Chief Technical Officer at Fusion Antibodies plc


Richard has 24 years’ experience in the biopharmaceutical industry. Richard has a PhD from Queen’s University Belfast in Immunology. He spent 4 years, discovering novel antibodies for diagnostics from synthetic libraries and joined Fusion Antibodies in 2002, where he was responsible for overseeing the Company’s Contract Research Services and production of all reagents required for the research and development of internal drug assets. He was appointed CTO in 2011, managing all scientific projects and Fusion Antibodies’ patent portfolios. In 2020 he was appointed as CSO.

Agenda Sessions

  • OptiMAL® - A Novel Library and Mammalian Display Platform for Antibody Discovery